Trials that use: Risk difference
New to this method? Read the tutorial →
4,772 results
- contRAst 2Complete statistical analysis of the phase 3 contRAst 2 trial of GSK3196165 (otilimab) versus placebo and tofacitinib in moderately to severely active rheumatoid arthritis.
- Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Contrast-enhanced Ultrasound Evaluation of Chemoembolization: Complete Statistical AnalysisIndependent statistical analysis of Contrast-enhanced Ultrasound Evaluation of Chemoembolization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02764801).
- CONTROLIndependent statistical analysis of Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00184548).
- Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ): Complete Statistical AnalysisIndependent statistical analysis of Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for Vocal Fold Scarring and Age-Related Dysphonia: Complete Statistical AnalysisIndependent statistical analysis of Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for Vocal Fold Scarring and Age-Related Dysphonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Convalescent Plasma vs. Standard Plasma for COVID-19: Complete Statistical AnalysisIndependent statistical analysis of Convalescent Plasma vs. Standard Plasma for COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04344535).
- Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection: Complete Statistical AnalysisIndependent statistical analysis of Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03762473).
- Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy: Complete Statistical AnalysisIndependent statistical analysis of Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- COOLIndependent statistical analysis of A Proof of Concept Study to Investigate the Use and Relevance of a Digital Platform for Infant Crying and Fussing: primary endpoint results, effect estimate with confidence interval,…
- Coordinated Emergency Department Transitions: Complete Statistical AnalysisIndependent statistical analysis of Coordinated Emergency Department Transitions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06933849).
- Coordinated Oral Health Promotion (CO-OP) Chicago: Complete Statistical AnalysisIndependent statistical analysis of Coordinated Oral Health Promotion (CO-OP) Chicago: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03397589).
- COPDIndependent statistical analysis of A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- COPPSIndependent statistical analysis of COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04662073).
- Coronary MDCTA With Iopamidol Injection 370: Complete Statistical AnalysisIndependent statistical analysis of Coronary MDCTA With Iopamidol Injection 370: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00558792).
- CorPath® GRX Neuro Study: Complete Statistical AnalysisIndependent statistical analysis of CorPath® GRX Neuro Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04236856).
- COSMOSIndependent statistical analysis of A Study Assessing Arrhythmia Mapping With a Globe-Shaped, High-Density, Multi-Electrode Mapping Catheter: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- COSMOSIndependent statistical analysis of A Study in Participants With Non-cirrhotic NASH With Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05638737).
- Cost Comparison of Cardiac Magnetic Resonance Imaging (MRI) Use in Emergency Department (ED) Patients With Chest Pain: Complete Statistical AnalysisIndependent statistical analysis of Cost Comparison of Cardiac Magnetic Resonance Imaging (MRI) Use in Emergency Department (ED) Patients With Chest Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- COVACTAIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- CoverEdge Algorithm Programming Study: Complete Statistical AnalysisIndependent statistical analysis of CoverEdge Algorithm Programming Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02492880).
- COVID SAFE 2Independent statistical analysis of COVID-19 Screening Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05216627).
- COVID-19Independent statistical analysis of Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05973006).
- COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability: Complete Statistical AnalysisIndependent statistical analysis of COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05584189).
- COVID-19 PrEP HCW HCQ Study: Complete Statistical AnalysisIndependent statistical analysis of COVID-19 PrEP HCW HCQ Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04354870).
- COVID-AntibodyIndependent statistical analysis of Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04334876).
- COViNOXIndependent statistical analysis of A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- COVIPACT 2Independent statistical analysis of Psychological Care of Oncology Patients With Post-traumatic Stress in the Context of a COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- COZIIndependent statistical analysis of CBT-I or Zolpidem/Trazodone for Insomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04468776).
- CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01653158).
- CPIT001Independent statistical analysis of Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old: Complete Statistical AnalysisIndependent statistical analysis of CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients: Complete Statistical AnalysisIndependent statistical analysis of CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients: primary endpoint results, effect estimate with confidence interval,…
- CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus: Complete Statistical AnalysisIndependent statistical analysis of CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Cranberry Effect on Urinary Tract Infections: Complete Statistical AnalysisIndependent statistical analysis of Cranberry Effect on Urinary Tract Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02996981).
- Cranial Blocks for Postoperative Anesthesia: Complete Statistical AnalysisIndependent statistical analysis of Cranial Blocks for Postoperative Anesthesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04749797).
- CRATUSIndependent statistical analysis of AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- CRC027Independent statistical analysis of Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CREDO 2Complete statistical analysis of the phase 3 CREDO 2 trial evaluating two olokizumab dosing regimens versus placebo and adalimumab in patients with active rheumatoid arthritis receiving methotrexate.
- CREDO 2Independent statistical analysis of Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate…
- CriSP-HSIndependent statistical analysis of Cold Stored Platelet in Hemorrhagic Shock: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04667468).
- CRISTALLOIndependent statistical analysis of A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Rituximab (FCR)/ Bendamustine And Rituximab (BR) in FIT…
- CROSSIndependent statistical analysis of Cesarean Trial of Staples vs. Sutures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01211600).
- Cross-vaccination Study of GSK Biologicals’ Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies.: Complete Statistical AnalysisIndependent statistical analysis of Cross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies.: primary endpoint results,…
- CROWN CORONAIndependent statistical analysis of the randomized phase 3 CROWN CORONA trial evaluating M-M-R II vaccine versus placebo for prevention of symptomatic COVID-19, including Bayesian logistic regression, risk differences, confidence intervals, p-values, and…
- CROWN CORONAIndependent statistical analysis of CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04333732).
- CRP-TrackIndependent statistical analysis of Evaluation of the Predictive Nature of the Postoperative CRP on Postoperative Recovery in Patients Undergoing Colorectal Resection (CRP-Track): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- CRUSHIndependent statistical analysis of Connecting Resources for Urban Sexual Health: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02183909).
- CRYO-AFIndependent statistical analysis of Evaluation of the Cardioblate CryoFlex Surgical Ablation System in Longstanding Persistent Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Cryoablation for Invasive Breast Carcinoma Following Neoadjuvant Therapy: Complete Statistical AnalysisIndependent statistical analysis of Cryoablation for Invasive Breast Carcinoma Following Neoadjuvant Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01388777).